Ansell Grimm & Aaron Congratulates Clients for Securing Cannabis Licenses
March 8, 2023
Ansell Grimm & Aaron, PC is pleased to congratulate its latest clients to secure annual cannabis licenses from the Cannabis Regulatory Commission. The Social Leaf, LLC was awarded an Annual Class Five Retailer License, and CSDE Manufacturing, LLC was awarded an Annual Class One Cultivator License. The Commission issues licenses for medicinal and recreational cannabis […]
Read More »
9th Circuit to Decide Whether the Federal Government Can Continue to Deprive End-of-Life Patients of Psilocybin's Palliative Benefits
March 5, 2023
By Joshua S. Bauchner and Rahool Patel Much ink has been spilled over the past decade about the absurdity of the federal government’s insistence on maintaining marijuana’s listing as a Schedule I drug with “no accepted medical use” under the Controlled Substances Act (CSA) despite ample evidence of and consensus about marijuana’s therapeutic and medical […]
Read More »
CONTROLLED SUBSTANCES AND REGULATORY LAW DEPARTMENT UPDATE - FEBRUARY 2023
February 16, 2023
Ansell Files Amicus Curiae Brief In Support Of De-Scheduling Psilocybin Ansell Grimm & Aaron, PC once again proudly joins the National Organization for the Reform of Marijuana Laws (“NORML”) in securing access for patients, especially veterans, to the scientifically established medicinal benefits of psilocybin. Americans waited a half-century before gaining […]
Read More »
